The graft-versus-neuroblastoma effect of allogeneic hematopoietic stem cell transplantation, a review of clinical and experimental evidence and a perspective on mechanisms-Reference-Cited by-同舟云学术

The graft-versus-neuroblastoma effect of allogeneic hematopoietic stem cell transplantation, a review of clinical and experimental evidence and a perspective on mechanisms

Published:2014-08-23 Issue:12 Volume:61 Page:2151-2157
ISSN:1545-5009
Container-title:Pediatric Blood & Cancer
language:en
Short-container-title:Pediatr Blood Cancer

Author:

Willems Leen¹,Waer Mark¹,Billiau An D.¹

Affiliation:

1. Laboratory of Experimental Transplantation; KULeuven; Leuven Belgium

Publisher

Wiley

Subject

Oncology,Hematology,Pediatrics, Perinatology, and Child Health

Reference88 articles.

1. Neuroblastoma;Maris;Lancet,2007

2. Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. Children's Cancer Group;Matthay;N Engl J Med,1999

3. Recent advances in neuroblastoma;Maris;N Engl J Med,2010

4. Retinoids and the control of growth/death decisions in human neuroblastoma cell lines;Melino;J Neurooncol,1997

5. The effects of retinoic acid on the in vitro and in vivo growth of neuroblastoma cells;Abemayor;Laryngoscope,1992

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Phase II Study of Allogeneic Hematopoietic Stem Cell Transplantation for Children with High-Risk Neuroblastoma Using a Reduced-Intensity Conditioning Regimen: Results from the AIEOP Trial;Transplantation and Cellular Therapy;2024-05

2. Stem Cell Therapy for High-Risk Neuroblastoma: Stem Cell Transplantation and Targeting Cancer Stem Cells;Comprehensive Hematology and Stem Cell Research;2024

3. Anti-GD2 Antibody Dinutuximab Beta and Low-Dose Interleukin 2 After Haploidentical Stem-Cell Transplantation in Patients With Relapsed Neuroblastoma: A Multicenter, Phase I/II Trial;Journal of Clinical Oncology;2023-06-10

4. Immunotherapy for neuroblastoma by hematopoietic cell transplantation and post-transplant immunomodulation;Critical Reviews in Oncology/Hematology;2023-05

5. Risk factors associated with metastatic site failure in patients with high-risk neuroblastoma;Clinical and Translational Radiation Oncology;2022-05